Access cutting-edge melanoma treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and neck cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this melanoma clinical trial in Beverly Hills, CA
If you're searching for melanoma treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.